REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients
Clinical trial NCT00663416 · TERMINATED
Trial details
- NCT number
- NCT00663416
- Sponsor
- Stem Cell Therapeutics Corp.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2008-10-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.